bluuebunny/crossref_metadata_2025_split huggingface dataset:
Red wine extract, resveratrol, on maintenance of organ function following trauma-hemorrhage
Authors: Liu Fu-Chao , Yu Huang-Ping 
Published: August 2018

Resveratrol, is a polyphenol that can be extracted from grapes and red wine, possess potential anti-inflammatory effects, which would result in the reduction of cytokine production, the alteration of the expression of adhesion molecule molecules, and the inhibition of neutrophil function. Resveratrol might also act as an antioxidant, anti-aging, and control of cell cycle and apoptosis. Resveratrol has been shown to have protective effects for patients in shock-like states. Such protective phenomenon is reported to be implicated in a variety of intracellular signaling pathways including the regulation of the mitogen-activated protein kinases (MAPK)/ hemeoxygenase-1 (HO-1) pathway, activates estrogen receptor (ER), and the mediation of pro-inflammatory cytokines, reactive oxygen species (ROS) formation and reactive. Moreover, through anti-inflammatory effects and antioxidant properties, the resveratrol is believed to maintain organ function following trauma-hemorrhage.Key words: resveratrol, anti-inflammatory, trauma-hemorrhage.
Biochemical evaluation of the effects of Nigerian polyherbal preparation on Wistar rabbits
Authors: Anugweje Ken C. , Ojiako Okey A. , Igwe Chidi U. , Nwachukwu Winnifred A. , Ogbuji Chiza A. 
Published: August 2018

Background: Diabetes mellitus is a metabolic disorder with multiple etiologies. Its sufferers are generally at high risk of dyslipidemia characterized by hypercholesterolemia, hyper-triglyceridemia, hyperlipoproteinemia and low levels of high-density lipoprotein cholesterol. Globally, the estimated cost of diabetes care was $376 billion in 2010, representing 12% of health expenditures for that year. Methods: The effects of the aqueous extracts of a little known Nigerian traditional polyherbal formula consisting of Emilia coccinea, Acanthus montanus, Hibiscus rosasinensis and Asystasia gangetica on serum glucose concentration, amylase activity and lipid profiles of normal, diabetic, and liver-damaged rabbits were studied using standard procedures. The mixture of the aqueous extracts of the four plants was orally administered in two doses – 120mg/kg body weight and 240mg/kg body weight for 28 days. Results: The drug elicited dose- and duration-of-administration-dependent, significant (p<0.05) reductions in serum levels of glucose, total cholesterol, triacylglycerol and LDL-cholesterol; and significant (p<0.05) increases in the HDL-cholesterol concentrations with no changes in amylase activity.Conclusion: These results confirm the hypoglycemic, antihyperlipidemic and hepatoprotective potentials of the crude drug and thus justify its application in ethnomedicine in the management of diabetes. Key words: Emilia coccinea, Acanthus montanus, Hibiscus rosasinensis, Asystasia gangetica, antidiabetic, hepatoprotection.
Flavonoids and phenolic acids from pearl millet (Pennisetum glaucum) based foods and their functional implications
Authors: Nambiar Vanisha S. , Sareen Neha , Daniel Mammen , Gallego Erick B. 
Published: August 2018

Background: Pearl millet (Pennisetum glaucum), considered a poor man’s cereal, may be a repository of dietary antioxidants, especially flavonoids and phenolic acids, which provide bioactive mechanisms to reduce free radical induced oxidative stress and probably play a role in the prevention of ageing and various diseases associated with oxidative stress, such as cancer, cardiovascular, and neurodegenerative diseases.Objective: The present study focused on the identification of individual flavonoids and phenolic acids from seven commercial varieties of pearl millet and five samples of pearl millet-based traditional recipes of Banaskantha, Gujarat, India.Methods: Total phenols were determined by the Folin-Ciocalteu method, and individual polyphenol separation included the isolation and identification of (a) flavonoids, (b) phenolic acids, and (c) glycoflavones involving interaction with diagnostic reagents and paper chromatographic separation of compounds and their UV-visible spectroscopic studies including hypsochromic and bathchromic shifts with reagents such as AlCl3, AlCl3/HCl, NaOMe, NaOAc, and NaOAc/H3PO3. Five traditional recipes consumed in the pearl millet producing belt of Banaskantha, Gujarat, India, were standardized in the laboratory and analyzed for phenol and individual flavonoids. Results: Total phenols in raw samples ranged from 268.5 - 420mg/100g of DW and 247.5 - 335mg/100g of DW in cooked recipes. The commonly identified flavonoids were tricin, acacetin, 3, 4 Di-OMe luteolin, and 4-OMe tricin. Five phenolic acids were identified: namely vanilic acid, syringic acid, melilotic acid, para-hydroxyl benzoic acid, and salicylic acid.Conclusion: The presence of flavonoids, such as tricin, acacetin, 3, 4 Di-OMe luteolin, and 4-OMe tricin, indicate the chemopreventive efficacy of pearl millet. They may be inversely related to mortality from coronary heart disease and to the incidence of heart attacks in the pearl millet consuming belts of the world.Keywords: Polyphenols, Antioxidant, Flavonoids, Total Phenols, Pearl Millet (raw and cooked) (Pennisetum glaucum), Banaskantha, Gujarat
Angiotensin-converting enzyme inhibitory effects of dairy- and soy-derived peptides in pre-hypertensive overweight men and women
Authors: Munn Melissa S. , Sibley Shalamar , Brundage Richard , Ismail Baraem , Earthman Carrie P. 
Published: August 2018

Background: Hypertension is considered the most prevalent cardiovascular disorder and a significant public health problem. A functional food that could potentially impede progression into a hypertensive state in pre-hypertensive individuals is of significant interest to clinicians and consumers. In vitro and animal studies suggest the presence of potential ACE inhibitory dairy-and soy-derived peptides. Very few human-based research studies have been conducted to investigate the blood pressure lowering and/or ACE-inhibitory effects of whey and soy protein hydrolysates in humans. This pilot study tested the acute effects of 20g doses of whey and soy hydrolysates in pre-hypertensive, overweight men and postmenopausal women on serum ACE activity and blood pressure. Findings: Using a randomized crossover design, four initial subjects received five treatments (unhydrolyzed casein, whey protein isolate, whey protein hydrolysate, soy protein isolate, soy protein hydrolysate) at different testing visits separated by three-day washout periods. Blood pressure and blood draws to measure ACE activity were taken at thirty minute intervals following treatment consumption. Both the soy protein and whey protein hydrolysates had notable in vitro ACE-inhibitory activity, both before and after heat treatment. No differences were observed among the protein treatments for either ACE activity or systolic blood pressure. Conclusions: The results of this pilot study support a discrepancy between in vitro and human-based in vivo ACE-inhibitory acute effects of whey and soy protein hydrolysates, underscoring the need for further research to better understand potential explanations for these findings. Key Words: ACE (Angiotensin-converting enzyme), Casein, Soy, Whey, Protein, Blood pressure, Dairy, Bioactive, Peptides
Krill protein hydrolysate reduces plasma triacylglycerol level with concurrent increase in plasma bile acid level and hepatic fatty acid catabolism in high-fat fed mice
Authors: Ramsvik Marie S. , Bjørndal Bodil , Vik Rita , Bruheim Inge , Skorve Jon , Berge Rolf K. 
Published: August 2018

Background: Krill powder, consisting of both lipids and proteins, has been reported to modulate hepatic lipid catabolism in animals. Fish protein hydrolysate diets have also been reported to affect lipid metabolism and to elevate bile acid (BA) level in plasma. BA interacts with a number of nuclear receptors and thus affects a variety of signaling pathways, including very low density lipoprotein (VLDL) secretion. The aim of the present study was to investigate whether a krill protein hydrolysate (KPH) could affect lipid and BA metabolism in mice. Method: C57BL/6 mice were fed a high-fat (21%, w/w) diet containing 20% crude protein (w/w) as casein (control group) or KPH for 6 weeks. Lipids and fatty acid composition were measured from plasma, enzyme activity and gene expression were analyzed from liver samples, and BA was measured from plasma.Results: The effect of dietary treatment with KPH resulted in reduced levels of plasma triacylglycerols (TAG) and non-esterified fatty acids (NEFAs). The KPH treated mice had also a marked increased plasma BA concentration. The increased plasma BA level was associated with induction of genes related to membrane canalicular exporter proteins (Abcc2, Abcb4) and to BA exporters to blood (Abcc3 and Abcc4). Of note, we observed a 2-fold increased nuclear farnesoid X receptor (Fxr) mRNA levels in the liver of mice fed KPH. We also observed increased activity of the nuclear peroxiosme proliferator-activated receptor alpha (PPARα) target gene carnitine plamitoyltransferase 2 (CPT-2). Conclusion: The KPH diet showed to influence lipid and BA metabolism in high-fat fed mice. Moreover, increased mitochondrial fatty acid oxidation and elevation of BA concentration may regulate the plasma level of TAGs and NEFAs.Key words: Krill protein hydrolysate, triacylglycerol, fatty acids, TNFα
Anti-inflammatory, anthropometric and lipomodulatory effects Dyglomera® (aqueous extract of Dichrostachys glomerata) in obese patients with metabolic syndrome
Authors: Kuate Dieudonne , Etoundi Blanche C. , Ngondi Judith L. , Muda Wan , Oben Julius E. 
Published: August 2018

Background: Increased visceral fat, dyslipidemia and increased markers of inflammation and coagulation are cardiovascular risk factors commonly encountered in obese people with metabolic syndrome. Previous studies have shown that ground Dichrostachys glomerata (DG), a spice used in Western Cameroon, can have beneficial effects on inflammation and various other cardiovascular disease risk factors. The purpose of the present study was to evaluate the effects of Dyglomera®, an aqueous extract of DG (standardized to NLT 10% polyphenols) on certain anthropometric, biochemical (including pro-inflammatory and pro-thrombotic states) and hemodynamic parameters in obese patients with metabolic syndrome.Methods: The study was an 8-week randomized, double-blind, placebo-controlled trial involving 116 males and 202 females aged between 24 and 58 years. Participants were randomly divided into two groups: treatment and placebo. Capsules containing the active treatment (200 mg Dyglomera®) or placebo (200 mg maize powder) were administered 30–60 minutes before lunch and dinner throughout the study period. Various biochemical (namely, blood glucose, lipid profile, pro-inflammatory and pro-thrombotic markers), anthropometric and hemodynamic parameters were measured at baseline and after 4 and 8 weeks of treatment.Results: At the end of the study, the Dyglomera® group showed statistically significant differences in all 16 parameters compared to baseline values. Changes in BMI and waist circumference were accompanied by changes in biochemical parameters, with the exception of adiponectin levels which were not correlated to waist circumference and PAI-1 values. The results confirm the hypothesis that Dyglomera®, the aqueous extract of DG, has anti-inflammatory properties, and is effective in reducing cardiovascular disease risk factors associated with metabolic syndrome in obese human subjects.Key words: Dichrostachys glomerata extract, inflammation, obesity, metabolic syndrome
Functional foods for weight management: Dietary Fiber – a systematic review
Authors: Boaz Mona , Leibovitz Eyal , Wainstein Julio 
Published: August 2018

It has been estimated that more than 1.5 billion adults are overweight or obese worldwide [1], rendering obesity a global epidemic [2]. Obesity is associated with significant morbidity, including type 2 diabetes, cardiovascular disease, osteoarthritis and some cancers [3]. Thus, obesity is clearly a medical issue, its costs impacting heavily on health care systems in both developed and developing nations [4]. The combined impact of transmissible and chronic disease in the third world is particularly devastating to the very health care systems with fewest resources [5]. Because obesity has been identified as a major health issue, treating obesity is an important goal. However, weight loss management has proven notoriously difficult. It is well documented that reduced energy intake and increased energy expenditure may reduce body weight in the short term, but obesity relapse is the long term is anticipated [6]. In a study of overweight or obese US adults who weighed ≥ 10% less than their maximum body weight the year prior to the survey (n=1310), 33.5% regained > 5% during that year [7]. Despite its somewhat unimpressive success rate, "lifestyle" weight management remains the first line intervention for obesity treatment [8]. Lifestyle weight management can be defined as interventions based on energy restriction (weight loss diet); increased energy output (exercise); and/or behavioral change (cognitive or behavior therapy). Functional foods have been explored as a tool for enhancing lifestyle weight management. Functional foods evaluated for their efficacy as obesity interventions can be divided into two broad categories: 1) foods which suppress appetite and increase satiety; and 2) foods which enhance thermogenesis. The present review will focus on those foods thought to act by increasing satiety and suppressing appetite. Key words: Obesity, weight loss, systematic review, dietary fiber
The influence of obesity in patients with prostate cancer - Review of the literature
Authors: Goris Gbenou Maximilien C. 
Published: August 2018

Recent studies have demonstrated an association between higher body mass index and increased aggressiveness in prostate cancer. The present narrative review, based on a search of Medline® and Embase® databases from October 1982 to October 2012, explores the relationship between higher body mass index and localized prostate cancer. In particular, the current epidemiological and mechanistic evidence for interactions between obesity and prostate cancer are discussed. Obesity is associated with alterations in androgen levels, decreased sex hormone binding globulin and increased estrogen levels, insulin resistance, hyperglycemia, alterations in plasma lipoprotein levels particularly raised triglycerides and reduced high density lipoprotein, decreased levels of adiponectin, and increased levels of circulating insulin-growth factor- 1, leptin and dietary saturated fats. Obese men have more aggressive prostate cancer with a greater percentage prostate involvement, increased tumor volume and higher-grade disease, enlarged prostates, high prostate-specific antigen levels, increased risk of having positive margins and recurrence. Moreover, there is strong evidence of the beneficial effects of functional foods for the treatment of obesity. Additionally, an increasing number of studies support that obesity-induced inflammation plays an important role in the development of obesity-related pathologies. Despite, the beneficial role of nutriment in prostate cancer control, the use of functional foods in prostate cancer is not recommended for lack of large epidemiological studies. This data supports the hypothesis that obese men have more aggressive prostate cancers and that the obesity is a modifiable risk factor of prostate cancer. Key Words: prostate cancer, metabolic syndrome, obesity, high BMI, risk factor, diet, functional foods.
Inhibition of SIRT1 Transcription in Resveratrol-differentiated Medulloblastoma Cells
Authors: Ma Jing-Xin , Li Hong , Cheng Xiao-Xin , Wu Mo-Li , Yu Li-Jun , Kong Qing-You , Liu Ming , Liu Jia 
Published: August 2018

Backgrounds: Medulloblastoma (MB) is the commonest brain malignancy in childhood with poor prognosis, because of its rapid aggressive growth and frequent occurrence. The current chemotherapeutic regimens for medulloblastoma patients involve a combination of lomustine, cisplatin, carboplatin, vincristine or cyclophosphamide, which have distinct short- and long-term side-effects. It is therefore in urgent need to explore safer and more effective adjuvant approach(s). Resveratrol, a polyphenol rich in numerous plants, has multiple biological activities including anticancer effects. Our previous data confirmed that resveratrol inhibited proliferation and induced differentiation and apoptosis of medulloblastoma cells. SIRT1 is a deacetylase of class III HDACs and the supposed molecular effecter of resveratrol. SIRT1 involves in aging prevention and cancer formation in a cell-context specific manner. Nevertheless, the datum concerning the role(s) of SIRT1 in formation and prognosis of medulloblastoma is still missing.Objective: The present study aimed to address the expression patterna of SIRT1 in medulloblastoma tissues and non-cancerous counterparts and to explore whether resveratrol exerts its anti-medulloblastoma effects via regulating SIRT1 expression and bioactivity.Methods: The expression of SIRT1 in medulloblastoma and non-cancerous counterparts was elucidated by immunohistochemical ataining (IHC). To clarify the function of SIRT1 in medulloblastomas, SIRT1 expression in UW228-3 medulloblastoma cells were suppressed by RNA interference (RNAi). The influence of resveratrol in SIRT1 expressions in UW228-3 cells was analyzed by reverse transcription-polymerase chain reaction (RT-PCR), immunocytochemistry (ICC) and Western blotting (WB). The catalytic activity of deacetylase SIRT1 was examined by measuring the acetylation of the main substrate p53.Results: IHC staining revealed that SIRT1 was expressed in 64.17% of MB tissues, which was higher than that in noncancerous cerebellum tissues (14.29%). The frequencies of SIRT1 expression in the nodular MB (22.22%) with better prognosis is lower than that in anaplastic MB (79.07% ) and classic MB (60.29 %; P<0.05). The proliferation of UW228-3 cells was remarkably suppressed after being transfected with SIRT1 siRNA, accompanied with extensive cell death. The results of RT-PCR and WB showed that after 48 hours 100 M resveratrol treatment, SIRT1 expression in UW228-3 cells was down-regulated at both transcriptional and translational levels. However, resveratrol has no effect on the deacetylase activity of SIRT1.Conclusion: The above findings suggested that SIRT1 expression is corrected with the formation and prognosis of human MB. Resveratrol influences SIRT1 functioning in human MB cells through inhibiting SIRT1 expression rather than modulating its acetylation activity.Keywords: resveratrol, SIRT1, RNA interference, deacetylase, medulloblastoma
Bioactive form of resveratrol in glioblastoma cells and its safety for normal brain cells
Authors: Shu Xiao-Hong , Li Hong , Sun Xiao-Xin , Sun Zheng , Wang Li-Li , Song Xue , Shi Shun , Wu Mo-Li , Chen Xiao-Yan , Kong Qing-You , Jia Liu 
Published: August 2018

Background: Resveratrol, a plant polyphenol existing in grapes and many other natural foods, possesses a wide range of biological activities including cancer prevention. It has been recognized that resveratrol is intracellularly biotransformed to different metabolites, but no direct evidence has been available to ascertain its bioactive form because of the difficulty to maintain resveratrol unmetabolized in vivo or in vitro. It would be therefore worthwhile to elucidate the potential therapeutic implications of resveratrol metabolism using a reliable resveratrol-sensitive cancer cells.Objective: To identify the real biological form of trans-resveratrol and to evaluate the safety of the effective anticancer dose of resveratrol for the normal brain cells.Methods: The samples were prepared from the condition media and cell lysates of human glioblastoma U251 cells, and were purified by solid phase extraction (SPE). The samples were subjected to high performance liquid chromatography (HPLC) and liquid chromatography/tandem mass spectrometry (LC/MS) analysis. According to the metabolite(s), trans-resveratrol was biotransformed in vitro by the method described elsewhere, and the resulting solution was used to treat U251 cells. Meanwhile, the responses of U251 and primarily cultured rat normal brain cells (glial cells and neurons) to 100μM trans-resveratrol were evaluated by multiple experimental methods.Results: The results revealed that resveratrol monosulfate was the major metabolite in U251 cells. About half fraction of resveratrol monosulfate was prepared in vitro and this trans-resveratrol and resveratrol monosulfate mixture showed little inhibitory effect on U251 cells. It is also found that rat primary brain cells (PBCs) not only resist 100μM but also tolerate as high as 200μM resveratrol treatment. Conclusions: Our study thus demonstrated that trans-resveratrol was the bioactive form in glioblastoma cells and, therefore, the biotransforming activity of trans-resveratrol would be reversely correlated with the chemosensitivity of the treated cells. The findings from PBCs suggest that an effective anti-glioblastoma dose of resveratrol may not exert side-effect on normal brain cells, providing a strong evidence for practical use of resveratrol in the management of human brain malignancies.Key words: Resveratrol, glioblastoma, drug metabolism
Dietary omega-3 fatty acids and locomotor activity in an animal model of attention deficit hyperactivity disorder (ADHD)
Authors: Lange Klaus W. , Makulska-Gertruda Ewelina , Reisinger Jakob , Sontag Thomas-A. , Hauser Joachim 
Published: August 2018

Background: Attention deficit hyperactivity disorder (ADHD) is the most frequent behavioral disorder of childhood and is characterized by hyperactivity, attention problems and impulsivity. Pharmacological and behavioral therapies have been shown to be effective. In addition, the role of dietary compounds in the etiology and possibly the treatment of ADHD has attracted increasing attention. For example, the lack of dietary essential fatty acids has been suggested to be associated with symptoms of ADHD in humans.Objective: To investigate the effects of omega-3 polyunsaturated fatty acids (n-3 PUFAs) on locomotor activity in the spontaneously hypertensive rat (SHR) which has been proposed as an animal model of ADHD.Methods: Two groups of randomly assigned spontaneously hypertensive rats were fed with either n-3 PUFA-deficient or n-3 PUFA-enriched food (based on AIN93G) for six weeks and this was continued during the phase of behavioral testing. Locomotor activity was subsequently assessed using an open field test.Results: The results showed a marked difference in locomotor activity between the two groups of SHRs. In comparison with rats fed with n-3 deficient food, the animals on an n-3 enriched diet showed a statistically significant decrease in motor activity as assessed by the distance traveled.Conclusions: The present study demonstrates a marked reduction in locomotor activity following an n-3 PUFA-enriched diet in SHRs, i.e. the dietary enrichment with n-3 PUFAs reduced the motor activity in an established animal model of ADHD. Dietary n-3 PUFAs may therefore play a role in the pathophysiology of ADHD.Key words: omega-3 polyunsaturated fatty acids, attention deficit hyperactivity disorder, ADHD, animal model, spontaneously hypertensive rat, SHR, motor activity